Seizure freedom · adults (aged 18 years and over) with drug‐resistant epilepsy
1 finding from 1 review
50% or greater reduction in seizure frequency · children (aged 1 to 18 years) with drug‐resistant epilepsy
1 finding from 1 review
50% or greater reduction in seizure frequency · adults (aged 18 years and over) with drug‐resistant epilepsy
1 finding from 1 review
Adverse effects · adults (aged 18 years and over) with drug‐resistant epilepsy
1 finding from 1 review
Cognition and behaviour · adults (aged 18 years and over) with drug‐resistant epilepsy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · adults (aged 18 years and over) with drug‐resistant epilepsy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Attrition rate · adults (aged 18 years and over) with drug‐resistant epilepsy
1 finding from 1 review
Adverse effects · children (aged 1 to 18 years) with drug‐resistant epilepsy
1 finding from 1 review
Cognition and behaviour · children (aged 1 to 18 years) with drug‐resistant epilepsy
1 finding from 1 review
Quality of life · children (aged 1 to 18 years) with drug‐resistant epilepsy
It is very uncertain whether ketogenic diet (KD) changes quality of life compared with usual care (very low certainty).
1 finding from 1 review
Treatment withdrawal · children (aged 1 to 18 years) with drug‐resistant epilepsy
Ketogenic diet (KD) showed no clear difference in treatment withdrawal compared with usual care (low certainty).
1 finding from 1 review
Seizure freedom · adults (aged 16 years and over) with drug‐resistant epilepsy
It is very uncertain whether ketogenic diet (KD) changes seizure freedom compared with usual care (very low certainty).
1 finding from 1 review
50% or greater reduction in seizure frequency · adults (aged 16 years and over) with drug‐resistant epilepsy
It is very uncertain whether ketogenic diet (KD) changes 50% or greater reduction in seizure frequency compared with usual care (very low certainty).
1 finding from 1 review
Adverse effects · adults (aged 16 years and over) with drug‐resistant epilepsy
1 finding from 1 review
Prostate cancer incidence · adults (aged at least 18 years)
Green tea extract supplementation showed no clear difference in prostate cancer incidence compared with placebo (low certainty).
1 finding from 1 review
Stomach cancer risk (18 studies) · adults (aged at least 18 years)
It is very uncertain whether highest changes stomach cancer risk (18 studies) compared with lowest green tea exposure (very low certainty).
1 finding from 1 review
RR 0.86 [0.74, 1.01]
438595 participants
Very low
Liver cancer risk (6 studies) · adults (aged at least 18 years)
Highest showed no clear difference in liver cancer risk (6 studies) compared with lowest green tea exposure (low certainty).
1 finding from 1 review
RR 0.88 [0.68, 1.14]
198885 participants
Low
Pancreatic cancer risk (9 studies) · adults (aged at least 18 years)
Highest showed no clear difference in pancreatic cancer risk (9 studies) compared with lowest green tea exposure (low certainty).
1 finding from 1 review
RR 0.88 [0.7, 1.1]
326564 participants
Low
Colorectal cancer risk (16 studies) · adults (aged at least 18 years)
Highest may leads to lower colorectal cancer risk (16 studies) compared with lowest green tea exposure (low certainty).
1 finding from 1 review
RR 0.84 [0.74, 0.96]
610295 participants
Low
Colon cancer risk (10 studies) · adults (aged at least 18 years)
Highest may leads to lower colon cancer risk (10 studies) compared with lowest green tea exposure (low certainty).
1 finding from 1 review
RR 0.89 [0.8, 0.98]
389974 participants
Low